AKR1C3

AKR1C3
Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 1RY0, 1RY8, 1S1P, 1S1R, 1S2A, 1S2C, 1XF0, 1ZQ5, 2F38, 2FGB, 3R43, 3R58, 3R6I, 3R7M, 3R8G, 3R8H, 3R94, 3UFY, 3UG8, 3UGR, 3UWE, 4DBS, 4DBU, 4DBW, 4DZ5, 4FA3, 4FAL, 4FAM, 4H7C, 4HMN, 4WDT, 4WDU, 4WDW, 4WDX, 4WRH, 4XVD, 4XVE, 4ZFC, 4YVX, 4YVV
Identifiers
Aliases	AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS, aldo-keto reductase family 1, member C3
External IDs	MGI: 2145420 HomoloGene: 128661 GeneCards: AKR1C3
EC number	1.3.1.20
Targeted by Drug
tolfenamic acid[1]
Gene ontology Molecular function • delta4-3-oxosteroid 5beta-reductase activity • prostaglandin-F synthase activity • trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity • alditol:NADP+ 1-oxidoreductase activity • retinal dehydrogenase activity • geranylgeranyl reductase activity • indanol dehydrogenase activity • aldo-keto reductase (NADP) activity • dihydrotestosterone 17-beta-dehydrogenase activity • phenanthrene 9,10-monooxygenase activity • ketoreductase activity • oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor • testosterone dehydrogenase (NAD+) activity • retinol dehydrogenase activity • testosterone 17-beta-dehydrogenase (NADP+) activity • oxidoreductase activity • androsterone dehydrogenase activity • 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity • ketosteroid monooxygenase activity • NADP-retinol dehydrogenase activity • prostaglandin D2 11-ketoreductase activity • prostaglandin H2 endoperoxidase reductase activity Cellular component • cytoplasm • cytosol • intracellular • extracellular exosome • nucleus Biological process • cellular response to calcium ion • negative regulation of retinoic acid biosynthetic process • prostaglandin metabolic process • G-protein coupled receptor signaling pathway • cellular response to jasmonic acid stimulus • steroid metabolic process • positive regulation of protein kinase B signaling • male gonad development • positive regulation of cell death • daunorubicin metabolic process • doxorubicin metabolic process • response to nutrient • regulation of retinoic acid receptor signaling pathway • progesterone metabolic process • cellular response to starvation • regulation of testosterone biosynthetic process • protein import into nucleus, translocation • cellular response to cadmium ion • cellular response to corticosteroid stimulus • cyclooxygenase pathway • keratinocyte differentiation • retinal metabolic process • retinoid metabolic process • cellular response to reactive oxygen species • farnesol catabolic process • positive regulation of endothelial cell apoptotic process • positive regulation of reactive oxygen species metabolic process • cellular response to prostaglandin D stimulus • positive regulation of cell proliferation • oxidation-reduction process • multicellular organismal macromolecule metabolic process • renal absorption • testosterone biosynthetic process • cellular response to prostaglandin stimulus • retinol metabolic process Sources:Amigo / QuickGO
RNA expression pattern
More reference expression data
Orthologs
Species	Human	Mouse
Entrez	8644	105349
Ensembl	n/a	ENSMUSG00000021214
UniProt	P42330	Q8K023
RefSeq (mRNA)	NM_003739 NM_001253908 NM_001253909	NM_134066
RefSeq (protein)	NP_001240837.1 NP_003730.4	NP_598827.1
Location (UCSC)	Chr 10: 5.04 – 5.11 Mb	Chr 13: 4.13 – 4.15 Mb
PubMed search	[2]	[3]
Wikidata

View/Edit Human

View/Edit Mouse

Aldo-keto reductase family 1 member C3 is a key steroidogenic enzyme that in humans is encoded by the AKR1C3 gene.^[4][5][6]

Function

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14.^[6]

Pathology

AKR1C3 is overexpressed in prostate cancer (PCa) and is associated with the development of castration-resistant prostate cancer (CRPC). In addition, AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression.^[7]

References

1. "Drugs that physically interact with Aldo-keto reductase family 1 member C3 view/edit references on wikidata".
2. "Human PubMed Reference:".
3. "Mouse PubMed Reference:".
4. Khanna M, Qin KN, Wang RW, Cheng KC (Aug 1995). "Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases". The Journal of Biological Chemistry. 270 (34): 20162–8. doi:10.1074/jbc.270.34.20162. PMID 7650035.
5. Matsuura K, Shiraishi H, Hara A, Sato K, Deyashiki Y, Ninomiya M, Sakai S (Nov 1998). "Identification of a principal mRNA species for human 3alpha-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D2 11-ketoreductase activity". Journal of Biochemistry. 124 (5): 940–6. doi:10.1093/oxfordjournals.jbchem.a022211. PMID 9792917.
6. "Entrez Gene: AKR1C3 aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II)".
7. Tian Y, Zhao L, Zhang H, Liu X, Zhao L, Zhao X, Li Y, Li J (2014). "AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression". Diagnostic Pathology. 9 (1): 42. doi:10.1186/1746-1596-9-42. PMC 3939640. PMID 24571686.

External links

• Human AKR1C3 genome location and AKR1C3 gene details page in the UCSC Genome Browser.

Further reading

• Lin SX, Shi R, Qiu W, Azzi A, Zhu DW, Dabbagh HA, Zhou M (Mar 2006). "Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5". Molecular and Cellular Endocrinology. 248 (1-2): 38–46. doi:10.1016/j.mce.2005.11.035. PMID 16480815.
• Khanna M, Qin KN, Cheng KC (Jun 1995). "Distribution of 3 alpha-hydroxysteroid dehydrogenase in rat brain and molecular cloning of multiple cDNAs encoding structurally related proteins in humans". The Journal of Steroid Biochemistry and Molecular Biology. 53 (1-6): 41–6. doi:10.1016/0960-0760(95)00019-V. PMID 7626489.
• Nagase T, Miyajima N, Tanaka A, Sazuka T, Seki N, Sato S, Tabata S, Ishikawa K, Kawarabayasi Y, Kotani H (1995). "Prediction of the coding sequences of unidentified human genes. III. The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of cDNA clones from human cell line KG-1". DNA Research. 2 (1): 37–43. doi:10.1093/dnares/2.1.37. PMID 7788527.
• Khanna M, Qin KN, Klisak I, Belkin S, Sparkes RS, Cheng KC (Jan 1995). "Localization of multiple human dihydrodiol dehydrogenase (DDH1 and DDH2) and chlordecone reductase (CHDR) genes in chromosome 10 by the polymerase chain reaction and fluorescence in situ hybridization". Genomics. 25 (2): 588–90. doi:10.1016/0888-7543(95)80066-U. PMID 7789999.
• Qin KN, New MI, Cheng KC (Dec 1993). "Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase". The Journal of Steroid Biochemistry and Molecular Biology. 46 (6): 673–9. doi:10.1016/0960-0760(93)90308-J. PMID 8274401.
• Bennett MJ, Schlegel BP, Jez JM, Penning TM, Lewis M (Aug 1996). "Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+". Biochemistry. 35 (33): 10702–11. doi:10.1021/bi9604688. PMID 8718859.
• Lin HK, Jez JM, Schlegel BP, Peehl DM, Pachter JA, Penning TM (Dec 1997). "Expression and characterization of recombinant type 2 3 alpha-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3 alpha/17 beta-HSD activity and cellular distribution". Molecular Endocrinology. 11 (13): 1971–84. doi:10.1210/me.11.13.1971. PMID 9415401.
• Mills KI, Gilkes AF, Sweeney M, Choudhry MA, Woodgate LJ, Bunce CM, Brown G, Burnett AK (Nov 1998). "Identification of a retinoic acid responsive aldoketoreductase expressed in HL60 leukaemic cells". FEBS Letters. 440 (1-2): 158–62. doi:10.1016/S0014-5793(98)01435-5. PMID 9862446.
• Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V (Feb 1999). "Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase". Endocrinology. 140 (2): 568–74. doi:10.1210/en.140.2.568. PMID 9927279.
• Rheault P, Dufort I, Soucy P, Luu-The V (1999). "Assignment of HSD17B5 encoding type 5 17 beta-hydroxysteroid dehydrogenase to human chromosome bands 10p15-->p14 and mouse chromosome 13 region A2 by in situ hybridization: identification of a new syntenic relationship". Cytogenetics and Cell Genetics. 84 (3-4): 241–2. doi:10.1159/000015267. PMID 10393440.
• Griffin LD, Mellon SH (Nov 1999). "Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes". Proceedings of the National Academy of Sciences of the United States of America. 96 (23): 13512–7. doi:10.1073/pnas.96.23.13512. PMC 23979. PMID 10557352.
• Suzuki-Yamamoto T, Nishizawa M, Fukui M, Okuda-Ashitaka E, Nakajima T, Ito S, Watanabe K (Dec 1999). "cDNA cloning, expression and characterization of human prostaglandin F synthase". FEBS Letters. 462 (3): 335–40. doi:10.1016/S0014-5793(99)01551-3. PMID 10622721.
• Nishizawa M, Nakajima T, Yasuda K, Kanzaki H, Sasaguri Y, Watanabe K, Ito S (Feb 2000). "Close kinship of human 20alpha-hydroxysteroid dehydrogenase gene with three aldo-keto reductase genes". Genes to Cells. 5 (2): 111–25. doi:10.1046/j.1365-2443.2000.00310.x. PMID 10672042.
• Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K (Oct 2000). "Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones". The Biochemical Journal. 351 (Pt 1): 67–77. doi:10.1042/0264-6021:3510067. PMC 1221336. PMID 10998348.
• Hartley JL, Temple GF, Brasch MA (Nov 2000). "DNA cloning using in vitro site-specific recombination". Genome Research. 10 (11): 1788–95. doi:10.1101/gr.143000. PMC 310948. PMID 11076863.
• Penning TM, Burczynski ME, Jez JM, Lin HK, Ma H, Moore M, Ratnam K, Palackal N (Jan 2001). "Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3)". Molecular and Cellular Endocrinology. 171 (1-2): 137–49. doi:10.1016/S0303-7207(00)00426-3. PMID 11165022.
• Simpson JC, Wellenreuther R, Poustka A, Pepperkok R, Wiemann S (Sep 2000). "Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing". EMBO Reports. 1 (3): 287–92. doi:10.1093/embo-reports/kvd058. PMC 1083732. PMID 11256614.